FR2353285B1 - - Google Patents

Info

Publication number
FR2353285B1
FR2353285B1 FR7528462A FR7528462A FR2353285B1 FR 2353285 B1 FR2353285 B1 FR 2353285B1 FR 7528462 A FR7528462 A FR 7528462A FR 7528462 A FR7528462 A FR 7528462A FR 2353285 B1 FR2353285 B1 FR 2353285B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7528462A
Other languages
French (fr)
Other versions
FR2353285A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOMS LABORATOIRES
Original Assignee
DOMS LABORATOIRES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOMS LABORATOIRES filed Critical DOMS LABORATOIRES
Priority to FR7528462A priority Critical patent/FR2353285A1/en
Publication of FR2353285A1 publication Critical patent/FR2353285A1/en
Application granted granted Critical
Publication of FR2353285B1 publication Critical patent/FR2353285B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR7528462A 1975-09-17 1975-09-17 Coronary vasodilator controlled release dipyridamole compsn. - comprises film coated granules giving reduced side effects and also showing angina pectoris suppressing action Granted FR2353285A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7528462A FR2353285A1 (en) 1975-09-17 1975-09-17 Coronary vasodilator controlled release dipyridamole compsn. - comprises film coated granules giving reduced side effects and also showing angina pectoris suppressing action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7528462A FR2353285A1 (en) 1975-09-17 1975-09-17 Coronary vasodilator controlled release dipyridamole compsn. - comprises film coated granules giving reduced side effects and also showing angina pectoris suppressing action

Publications (2)

Publication Number Publication Date
FR2353285A1 FR2353285A1 (en) 1977-12-30
FR2353285B1 true FR2353285B1 (en) 1978-12-01

Family

ID=9160081

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7528462A Granted FR2353285A1 (en) 1975-09-17 1975-09-17 Coronary vasodilator controlled release dipyridamole compsn. - comprises film coated granules giving reduced side effects and also showing angina pectoris suppressing action

Country Status (1)

Country Link
FR (1) FR2353285A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367217A (en) 1980-01-12 1983-01-04 Boehringer Ingelheim Gmbh Dipyricamole sustained release forms comprising lacquer-coated particles and the preparation thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD146547A5 (en) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim MEDICINAL RETARDANT SHAPE WITH UNFORGETTABLE POROESEN DIFFUSION SHELLS
FR2432313A1 (en) * 1978-08-01 1980-02-29 Foulhoux Pierre Micro:granules contg. beta-histine - for controlled release and less side effects useful in treating Menieres syndrome
DE2950977A1 (en) * 1978-12-22 1980-07-10 Donald E Panoz NEW GALENIC PREPARATION FOR THE ORAL ADMINISTRATION OF MEDICINES WITH PROGRAMMED ASSOCIATION, AND METHOD FOR THE PRODUCTION THEREOF
FR2452923A2 (en) * 1979-04-02 1980-10-31 Panoz Donald Controlled release oral galenical formulation - contains active components in micro-granules prepd. under high compression
FR2470599A1 (en) * 1979-12-07 1981-06-12 Panoz Donald IMPROVEMENTS IN PROCESSES FOR THE PREPARATION OF GALENIC SHAPES WITH DELAYED ACTION AND PROGRAMMED RELEASE AND GALENIC FORMS OF MEDICAMENTS THUS OBTAINED
JPS5858146A (en) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd Microcapsule with fast releasability and preparation thereof
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
CA2431147A1 (en) * 2000-12-19 2002-06-27 Merck Patent Gesellschaft Mit Beschraenkter Haftung Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
MXPA03005393A (en) * 2000-12-19 2003-09-25 Merck Patent Gmbh Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives.
KR20030059351A (en) * 2000-12-19 2003-07-07 메르크 파텐트 게엠베하 Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DE10352511A1 (en) * 2003-11-07 2005-06-16 Ernst-Moritz-Arndt-Universität Greifswald Use of MRP4 inhibitors for the treatment and / or prophylaxis of cardiovascular diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367217A (en) 1980-01-12 1983-01-04 Boehringer Ingelheim Gmbh Dipyricamole sustained release forms comprising lacquer-coated particles and the preparation thereof

Also Published As

Publication number Publication date
FR2353285A1 (en) 1977-12-30

Similar Documents

Publication Publication Date Title
FR2353285B1 (en)
JPS5643924Y2 (en)
JPS5535109Y2 (en)
JPS51136992U (en)
JPS51125034U (en)
JPS51126686U (en)
JPS5198381U (en)
JPS51148307U (en)
JPS51119296U (en)
JPS5282158U (en)
FI751054A (en)
JPS5271921U (en)
CS170794B1 (en)
JPS5250333U (en)
CH600615A5 (en)
CH601723A5 (en)
CH598071A5 (en)
CH599297A5 (en)
CH598042A5 (en)
CH588681A5 (en)
CH597466A5 (en)
CH596506A5 (en)
CH595948A5 (en)
CH595939A5 (en)
CH595597A5 (en)

Legal Events

Date Code Title Description
ST Notification of lapse